Pediatrix CFO has 3,676 shares withheld for taxes

Pediatrix Medical Group, Inc. reported that its EVP, CFO and Treasurer, Kasandra H. Rossi, had 3,676 shares of common stock withheld on a Form 4 filing.

Rhea-AI Filing Summary

Pediatrix Medical Group, Inc. reported that its EVP, CFO and Treasurer, Kasandra H. Rossi, had 3,676 shares of common stock withheld on a Form 4 filing. These restricted shares were withheld at $19.85 per share to cover taxes due upon vesting, rather than being sold in the open market.

After this tax-withholding disposition, Rossi directly holds 73,300 shares of Pediatrix common stock. This type of transaction is a routine administrative step tied to equity compensation vesting.

Insider Trade Summary

Exercise Price or Tax Liability: 3,676 shares

Exercise Price or Tax Liability 1 txn

Insider Rossi Kasandra H

Role EVP, CFO and Treasurer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	3,676	$19.85	$73K

Holdings After Transaction: Common Stock — 73,300 shares (Direct)

Footnotes (1)

1. F1. Represents 3,676 restricted shares withheld for payment of taxes upon vesting of shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Pediatrix Medical Group (MD) report for Kasandra H. Rossi?

Pediatrix Medical Group reported a tax-withholding disposition by EVP, CFO and Treasurer Kasandra H. Rossi. 3,676 restricted shares of common stock were withheld to cover taxes due upon vesting, rather than representing an open-market sale of shares.

How many Pediatrix (MD) shares were withheld for taxes in the latest Form 4?

The Form 4 shows that 3,676 restricted shares of Pediatrix common stock were withheld. These shares were retained by the company to satisfy Rossi’s tax obligations arising from the vesting of equity awards, a common feature of stock-based compensation programs.

What price per share was used for the Pediatrix (MD) tax-withholding shares?

The tax-withholding disposition used a value of $19.85 per share for the 3,676 restricted shares. This figure is used to calculate the tax due upon vesting of the equity awards, as reflected in the reported Form 4 transaction details.

How many Pediatrix (MD) shares does Kasandra H. Rossi hold after the Form 4 transaction?

Following the tax-withholding disposition, Kasandra H. Rossi directly holds 73,300 shares of Pediatrix common stock. This post-transaction balance reflects her remaining direct ownership after 3,676 restricted shares were withheld to satisfy tax obligations on vesting.

Does the Pediatrix (MD) Form 4 show an open-market sale by the CFO?

The Form 4 describes a tax-withholding disposition under transaction code F, not an open-market sale. The 3,676 restricted shares were withheld by the company to pay taxes owed when equity awards vested, which is a routine administrative transaction.

What role does Kasandra H. Rossi hold at Pediatrix Medical Group (MD)?

Kasandra H. Rossi is identified as EVP, CFO and Treasurer of Pediatrix Medical Group. Her Form 4 filing reflects equity compensation activity related to her executive position, specifically the withholding of restricted shares to cover tax liabilities on vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 05:00 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rossi Kasandra H

(Last) (First) (Middle)

1301 CONCORD TERRACE

(Street)

SUNRISE FL 33323

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Pediatrix Medical Group, Inc. [ MD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CFO and Treasurer

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		F(1)		3,676	D	$19.85	73,300	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 3,676 restricted shares withheld for payment of taxes upon vesting of shares.

	/s/ Mary Ann E. Moore, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.